Sunitinib plus erlotinib versus placebo plus erlotinib in patients with previously treated advanced non-small-cell lung cancer: a phase III trial.
暂无分享，去创建一个
G. Scagliotti | R. Govindan | J. Strausz | Michael Thomas | S. Thongprasert | L. Tye | M. Krzakowski | J. von Pawel | A. Szczesna | R. Wierzbicki | R. Chao | M. Reck | P. Selaru | A. Makhson | N. Karaseva | Z. Pápai | Ke Zhang | I. Albert | J. Miziara | E. D. Pórtulas